Union Health Ministry Reclassifies Pregabalin Under Schedule H1 to Curb Misuse
4 hours agoSocial
32LENS
11 SourcesNew Delhi, India
TBNthebalanced.news

Union Health Ministry Reclassifies Pregabalin Under Schedule H1 to Curb Misuse

The Union Health Ministry has reclassified Pregabalin, a drug prescribed for chronic pain and neurological conditions, under Schedule H1 of the Drugs Rules, 1945 to address rising misuse, especially among youth. This change mandates that Pregabalin be sold only with a valid prescription from a registered medical practitioner, with retailers required to maintain detailed sales records. The ministry cited reports of illegal sales and seizures, emphasizing that violations will attract penal action under the Drugs and Cosmetics Act, 1940. The move aims to enhance monitoring, prevent unauthorized access, and curb abuse nationwide.

Political Bias
3%96%1%
Sentiment
59%
AI analysis of 5 sources · Published under editorial oversight by The Balanced News
Analysed 22 May 2026· How this analysis is produced· Editorial standards· Corrections

AI Analysis

Political bias across 11 sources
● Left 3%● Center 96%● Right 1%

The article group predominantly reflects official government perspectives, focusing on regulatory actions by the Union Health Ministry. Coverage centers on public health concerns and enforcement measures without partisan framing. There is limited representation of dissenting views or patient advocacy perspectives, resulting in a largely administrative and policy-driven narrative.

Sentiment — Neutral (59/100)

The overall tone across the articles is neutral to cautious, emphasizing regulatory measures and public health protection. While acknowledging the drug's medical uses, the coverage highlights concerns about misuse and enforcement actions. There is no sensationalism or emotive language, maintaining a factual and informative sentiment throughout.

How 5 sources covered this story

Each source's own headline, political lean, and sentiment — so you can see framing differences at a glance.

SourceTheir headlineBiasSentiment
thetribuneCentre puts drug pregabalin under Schedule H1 to prevent misuse - The TribuneCenterNeutral
ndtvCentre Puts Pain Drug Pregabalin Under Schedule H1 To Prevent AbuseCenterNeutral
news18Union Health Ministry brings pregabalin under Schedule H1 to prevent misuseCenterNeutral
economictimesPregabalin moved to Schedule H1 as centre cracks down on drug misuseCenterNeutral
hindustantimesTighter controls imposed on Pregabalin sale, distribution amid abuse concernsCenterNeutral

Coverage timeline

hindustantimes broke this story on 22 May, 06:25 am. Other outlets followed.

  1. 1
    hindustantimes22 May, 06:25 am
    Tighter controls imposed on Pregabalin sale, distribution amid abuse concerns
  2. 2
    economictimes22 May, 06:45 am
    Pregabalin moved to Schedule H1 as centre cracks down on drug misuse
  3. 3
    news1822 May, 07:02 am
    Union Health Ministry brings pregabalin under Schedule H1 to prevent misuse
  4. 4
    ndtv22 May, 07:05 am
    Centre Puts Pain Drug Pregabalin Under Schedule H1 To Prevent Abuse
  5. 5
    thetribune22 May, 07:19 am
    Centre puts drug pregabalin under Schedule H1 to prevent misuse - The Tribune

Lens Score breakdown

32/100
Public interest0/100
Coverage gap100%

Well-covered story — coverage matches public importance.

Who's involved

Institutions and figures named across source coverage.

Government
Union Health MinistryDrugs Technical Advisory BoardHealth MinistryFood and Drugs Administration Punjab

Story context

Category
Social
Location
New Delhi, India
Sources analysed
11
Last analysed
22 May 2026
Key entities
PregabalinDissociativeSeizureHistamine H1 receptorFibromyalgiaSedativeEuphoriaNeurological disorderPeripheral neuropathyChronic painPhysicianDrugs and Cosmetics Rules, 1945